Xceleron Inc Company Profile

02:52 EDT 21st June 2018 | BioPortfolio

Pioneer of Acceleratory Mass Spectrometry For Drug Development

Xceleron was founded in 1997 in York, UK and has since expanded its operations with a US facility in Maryland, providing bioanalytical accelerator mass spectrometry (AMS) services for accelerated early drug development.

The company pioneered human microdose and microtracer techniques using ultra-sensitive AMS to investigate the pharmacokinetics and metabolism of developmental drugs in Phase 0, Phase I and Phase II/III clinical trials. It has been providing drug development services for more than 10 years and has conducted more GLP and GCP studies than any other CRO of its type, with unmatched robust analytical processes and knowledge of experimental design.

Xceleron’s experience is especially valuable today because the characteristics of many contemporary small molecules (low solubility, long half-life and disproportionate human metabolites) mean that their early pharmacokinetic and metabolic characterization is critical to the cost-effectiveness of clinical development.



20340 Seneca Meadows Parkway
United States of America


Phone: +1 240 361 1900
Fax: +1 240 361 1901

News Articles [3 Associated News Articles listed on BioPortfolio]

Xceleron: Changing the Face of Clinical Trials

Fintan Walton talks to Professor Colin Garner, founder and CEO of Xceleron, a bioanalytical CRO that is changing the way drugs are developed. Established in 1997 as part of a transatlantic scientific ...

Xceleron Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19032018] Prices from USD $250

SummaryXceleron Inc Xceleron, a subsidiary of Pharmaron Inc is a contract research organization that offers analytical solutions for drug development programs. The organization provides pharmaceutical...

Redx Pharma appoints new chairman

Redx Pharma has today appointed Dr Frank Armstrong as its non-executive chairman. Frank, 57, brings a wealth of industry knowledge and highly relevant experience of oncology and anti-infectives, two ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Xceleron Inc

Pioneer of Acceleratory Mass Spectrometry For Drug Development Xceleron was founded in 1997 in York, UK and has since expanded its operations with a US facility in Maryland, providing bioanalytica...


Founded in 1997 in York, UK, Xceleron provides unique and robust human data and insights to inform the full range of decisions that determine drug development success, from early ...

More Information about "Xceleron Inc" on BioPortfolio

We have published hundreds of Xceleron Inc news stories on BioPortfolio along with dozens of Xceleron Inc Clinical Trials and PubMed Articles about Xceleron Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xceleron Inc Companies in our database. You can also find out about relevant Xceleron Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record